Search results
Found 30060 matches for
A new study by researchers at NDORMS, University of Oxford now published in Osteoarthritis and Cartilage found that the average lifetime risk of needing further surgery following knee and hip replacement – revision surgery – was around 5% after knee replacement and 8% after hip replacement, with neither body mass index (BMI, combining an individual's height and weight) or smoking having any meaningful effect on these risks.
MSD Mediation Service
Building better workplace relationships and equipping people to manage conflict better.
New theory for spontaneous reporting of suspected adverse drug reactions to biological therapies
Adverse drug reactions, commonly known as side effects, place a significant burden on health services and account for patient deaths, disease, and extra costs in the UK and worldwide. This research is about the reporting of side effects of biologic medicines on patients.
UK Human Functional Genomics Initiative: Musculoskeletal Cluster
Our research will use genetics to improve our understanding and treatment of musculoskeletal diseases, such as osteoarthritis and carpal tunnel syndrome, which cause more years of disability and pain than any other disease class.
2022-2024 cohort
Find out about our 2022-2024 alumni.
Meet the team
-
Ed Burn
Senior Researcher in Epidemiology and Health Economics
-
Daniel Prieto-Alhambra
Professor of Pharmaco- and Device Epidemiology
-
Rafael Pinedo Villanueva
Associate Professor
-
David Murray
Professor of Orthopaedic Surgery
-
Cyrus Cooper
Professor of Musculoskeletal Science, University of Oxford
Funder
Read the paper
The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data
Osteoarthritis and Cartilage, May 2019